AstraZeneca at PepTalk 2027
Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website
AstraZeneca brings 13 presentations to PepTalk 2027 in Carlsbad. Its sessions center on multispecific antibody design and on faster, more automated purification and quality checks for protein production. Specific work includes building multispecifics by protein trans-splicing, automated mass spectrometry quality checks, and trispecific T cell engagers tuned for more selective targeting.
| Organization | PepTalk 2027 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global pharmaceutical company developing antibodies, multispecifics and antibody-drug conjugates across oncology, respiratory, immunology and rare diseases. | Chair Mon Jan 18 8:50am–9:00am Talk Mon Jan 18 9:30am–10:00am Talk Mon Jan 18 11:45am–12:15pm Talk Tue Jan 19 11:20am–11:50am Panel Tue Jan 19 11:50am–12:20pm Chair Tue Jan 19 1:25pm–1:30pm Talk Wed Jan 20 11:10am–11:40am Talk Wed Jan 20 2:30pm–3:00pm Talk Thu Jan 21 9:10am–9:40am Talk Thu Jan 21 11:50am–12:20pm Talk Thu Jan 21 1:40pm–2:00pm Talk Thu Jan 21 2:40pm–3:10pm Panel Thu Jan 21 3:00pm–3:40pm |
Instantly find 20 buyers from AstraZeneca
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by PepTalk or its organizers. Submit a correction